281 related articles for article (PubMed ID: 28236499)
41. Trends in resistance to ciprofloxacin, cefazolin, and gentamicin in the treatment of bacterial keratitis.
Afshari NA; Ma JJ; Duncan SM; Pineda R; Starr CE; Decroos FC; Johnson CS; Adelman RA
J Ocul Pharmacol Ther; 2008 Apr; 24(2):217-23. PubMed ID: 18331204
[TBL] [Abstract][Full Text] [Related]
42. Trends in Microbiological and Antibiotic Sensitivity Patterns in Infectious Keratitis: 10-Year Experience in Mexico City.
Hernandez-Camarena JC; Graue-Hernandez EO; Ortiz-Casas M; Ramirez-Miranda A; Navas A; Pedro-Aguilar L; Lopez-Espinosa NL; Gaona-Juarez C; Bautista-Hernandez LA; Bautista-de Lucio VM
Cornea; 2015 Jul; 34(7):778-85. PubMed ID: 25811724
[TBL] [Abstract][Full Text] [Related]
43. Prevalence and antibiotic susceptibility of bacteria isolated in patients affected with blepharitis in a tertiary eye centre in Spain.
de Paula A; Oliva G; Barraquer RI; de la Paz MF
Eur J Ophthalmol; 2020 Sep; 30(5):991-997. PubMed ID: 31232091
[TBL] [Abstract][Full Text] [Related]
44. Prevalence and antimicrobial susceptibilities of anaerobic bacteria isolated from perforated corneal ulcers by culture and multiplex PCR: an evaluation in cases with keratitis and endophthalmitis.
Tokman HB; İskeleli G; Dalar ZG; Kangaba AA; Demirci M; Akay HK; Borsa BA; Algingil RÇ; Kocazeybek BS; Torun MM; Kiraz N
Clin Lab; 2014; 60(11):1879-86. PubMed ID: 25648030
[TBL] [Abstract][Full Text] [Related]
45. [Bacterial keratitis. Microbiological analysis as a principle for therapeutic recommendations].
Fröhlich SJ; Miño de Kaspar H; Grasbon T; Möhring C; Klauss V; Kampik A
Ophthalmologe; 1999 Jul; 96(7):459-64. PubMed ID: 10479898
[TBL] [Abstract][Full Text] [Related]
46. Stenotrophomonas maltophilia-A Case Series of a Rare Keratitis Affecting Patients With Bandage Contact Lens.
Hogg HDJ; Siah WF; Okonkwo A; Narayanan M; Figueiredo FC
Eye Contact Lens; 2019 Jan; 45(1):e1-e4. PubMed ID: 29369229
[TBL] [Abstract][Full Text] [Related]
47. Antibiotic resistance in microbial keratitis: ten-year experience of corneal scrapes in the United Kingdom.
Shalchi Z; Gurbaxani A; Baker M; Nash J
Ophthalmology; 2011 Nov; 118(11):2161-5. PubMed ID: 21764458
[TBL] [Abstract][Full Text] [Related]
48. Microbial keratitis in los angeles: the doheny eye institute and the los angeles county hospital experience.
Sand D; She R; Shulman IA; Chen DS; Schur M; Hsu HY
Ophthalmology; 2015 May; 122(5):918-24. PubMed ID: 25600200
[TBL] [Abstract][Full Text] [Related]
49. [In vitro antibiotic susceptibility to fluoroquinolones].
Wong CA; Galvis V; Tello A; Villareal D; Rey JJ
Arch Soc Esp Oftalmol; 2012 Mar; 87(3):72-8. PubMed ID: 22423655
[TBL] [Abstract][Full Text] [Related]
50. Microbial Keratitis Isolates at a Midwestern Tertiary Eye Care Center.
Kang L; Lu MC; Niziol LM; Greenwald MF; Mian SI; Thibodeau A; Pawar M; Lephart PR; Woodward MA
Cornea; 2023 Dec; 42(12):1488-1496. PubMed ID: 36716402
[TBL] [Abstract][Full Text] [Related]
51. Twelve-year analysis of microbial keratitis trends at a UK tertiary hospital.
Tan SZ; Walkden A; Au L; Fullwood C; Hamilton A; Qamruddin A; Armstrong M; Brahma AK; Carley F
Eye (Lond); 2017 Aug; 31(8):1229-1236. PubMed ID: 28452995
[TBL] [Abstract][Full Text] [Related]
52. Surveillance of the Activity of Aminoglycosides and Fluoroquinolones Against Ophthalmic Pathogens from Europe in 2010-2011.
Sanfilippo CM; Morrissey I; Janes R; Morris TW
Curr Eye Res; 2016 May; 41(5):581-9. PubMed ID: 26200173
[TBL] [Abstract][Full Text] [Related]
53. 12-year analysis of incidence, microbiological profiles and in vitro antimicrobial susceptibility of infectious keratitis: the Nottingham Infectious Keratitis Study.
Ting DSJ; Ho CS; Cairns J; Elsahn A; Al-Aqaba M; Boswell T; Said DG; Dua HS
Br J Ophthalmol; 2021 Mar; 105(3):328-333. PubMed ID: 32580955
[TBL] [Abstract][Full Text] [Related]
54. Corneal Culture and Antibiotic Susceptibility Results for Microbial Keratitis in the Mid-Atlantic Region of the United States, 2016 to 2020.
Shekhawat NS; Hall LN; Sulewski ME; Woreta F; Wang J; Smith K; Kuo IC
Eye Contact Lens; 2023 Jul; 49(7):267-274. PubMed ID: 37166232
[TBL] [Abstract][Full Text] [Related]
55. Antimicrobial susceptibility of isolated pathogens from patients with contact lens-related bacterial keratitis in Crete, Greece: A ten-year analysis.
Spernovasilis N; Maraki S; Kokorakis E; Kofteridis D; Tsilimbaris M; Siganos C; Samonis G
Cont Lens Anterior Eye; 2021 Aug; 44(4):101355. PubMed ID: 32778366
[TBL] [Abstract][Full Text] [Related]
56. Pediatric microbial keratitis in Taiwan: clinical and microbiological profiles, 1998-2002 versus 2008-2012.
Lee YS; Tan HY; Yeh LK; Lin HC; Ma DH; Chen HC; Chen SY; Chen PY; Hsiao CH
Am J Ophthalmol; 2014 May; 157(5):1090-6. PubMed ID: 24487048
[TBL] [Abstract][Full Text] [Related]
57. Infectious Keratitis Isolates and Susceptibility in Southern California.
Gupta K; Unhale R; Garner OB; Deng SX; M Fung SS
Cornea; 2022 Sep; 41(9):1094-1102. PubMed ID: 35315617
[TBL] [Abstract][Full Text] [Related]
58. Corynebacterium Keratitis: Pure Versus Mixed Infection and Antibiotic Susceptibility Patterns From Different Tertiary Eye Care Centers.
Soni T; Gunasekaran R; Das S; Mitra S; Prajna NV; Prajna L; Sharma S; Mohamed A
Cornea; 2022 Nov; 41(11):1386-1391. PubMed ID: 34743096
[TBL] [Abstract][Full Text] [Related]
59. Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy.
Sharma V; Sharma S; Garg P; Rao GN
Indian J Ophthalmol; 2004 Dec; 52(4):287-92. PubMed ID: 15693319
[TBL] [Abstract][Full Text] [Related]
60. [Clinical, microbiological and therapeutic features of severe bacterial keratitis].
Darugar A; Gaujoux T; Goldschmidt P; Chaumeil C; Laroche L; Borderie V
J Fr Ophtalmol; 2011 Jun; 34(6):362-8. PubMed ID: 21507512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
